The Role of Laryngopharyngeal Reflux in IPF

Abroad (travel likely)Recruiting

Conditions

IPF · Reflux

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Jewish Health, Denver, Colorado, United States
Contact: Study coordinator (Tara Churney, MPH) · ILDresearch@njhealth.org · 303-398-1996

Study leads

Matthew Koslow, DO
Principal Investigator
National Jewish Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE3

Palm Spring, United States · Redding, United States

Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE2

Danbury, United States · Windsor, Canada

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Progressive Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Los Angeles, United States

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE3

Beijing, China